PRPO — PRECIPIO INC (Healthcare >> Diagnostics & Research)
PRPO FAQ
What is PRPO's P/E ratio?
PRECIPIO INC (PRPO) currently trades at a P/E ratio of 68.40.
What is PRPO's ROE?
PRECIPIO INC reports a Return on Equity (ROE) of -6.51%.
What is PRPO's dividend yield?
PRECIPIO INC offers a dividend yield of 0.00%.
What is PRPO's Deepscope Quality Score?
Deepscope rates PRPO's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PRPO?
Deepscope's AI Timing Score for PRPO is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PRPO belong to?
PRECIPIO INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 24.04
Price
1.56
(6.94%)
Day Change
|
|
|---|
PRPO, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 24.04 |
| PBV / Sector |
2.90 / -23.97
|
| Earning Per Share | -0.54 |
| PE / Sector |
68.40 / 36.92
|
| PEG or PE/Growth / Sector |
-1.11 / 1.37
|
| Average 1M Daily Value |
0.91 M
GREAT
|
| Average 1W Daily Value |
0.99 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:21 |
| Symbol | PRPO |
| Name | PRECIPIO INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 1.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 41.04 / 31,486.64 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4 Science Park, New Haven, CT, United States, 06511
Phone: 203 787 7888
Website: https://www.precipiodx.com
Employees: 61
Description: Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
Google